A clinical study to study the effect of drug NELLI KUDINEER in RATHAMOOLAM(Bleeding Haemorrhoids)

A Prospective Open Labelled Phase II Non Randomized clinical study of NELLI KUDINEER for RATHAMOOLAM(Bleeding Haemorrhoids)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012713

Enrollment

Registered

2018-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- RATHAMOOLAM

Interventions

Intervention1: NELLI KUDINEER: 100ml Orally OD Before food for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with haemorrhoids in grade I II III with clinical symptoms such as Bleeding per rectum Irregular bowel habits Constipation Prolapse of pile mass Itching around anus Tenesmus and Anemia

Exclusion criteria

Exclusion criteria: Fissure Fistula in ano Prolapse of rectum Sentinel haemorrhoids Malignancy Rectal polyp Pregnant women Chronic Kidney,Liver and cardiac diseases

Design outcomes

Primary

Measure	Time frame
Therapeutic efficacy of trial drug Nelli kudineer in RathamoolamTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parameters Safety of trial drug Pharmacological and Biochemical analysis of trial drugTimepoint: 30 days	—

Countries

India

Contacts

Public ContactProf Dr A Manoharan MD

Govt Siddha Medical College and hospital Palayamkottai

drmanoharan25@Gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026